Trial Profile
A study on the safety and efficacy of cyclodextrin intrathecal administration in Niemann-Pick disease type C
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2016
Price :
$35
*
At a glance
- Drugs Adrabetadex (Primary)
- Indications Niemann-Pick disease type C
- Focus Therapeutic Use
- 15 Jul 2016 New trial record